Pleomorphic soft tissue myogenic sarcomas of adulthood: A reappraisal in the mid-1990s

American Journal of Surgical Pathology

Volumn 20, Issue 2, 1996, Pages 131-147

  Schürch, Walter ^a   Bégin, Louis R ^c   Seemayer, Thomas A ^h   Lagacé, Réal ^d   Boivin, Jean Claude ^e   Lamoureux, Christian ^b   Bluteau, Paul ^f   Piché, Jean ^g   Gabbiani, Giulio ⁱ  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e General Hospital of Verdun ^*  (United States)

^f General Hospital of Verdun   (Canada)

^g Pierre Boucher Hospital   (Canada)

^h UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Actin isoforms; Electron microscopy; Immunohistochemistry; Leiomyosarcoma; Pleomorphic sarcoma; Rhabdomyosarcoma

Indexed keywords

ACTIN; DESMIN; VIMENTIN;

ARTICLE; CELL ULTRASTRUCTURE; CYTOSKELETON; GROWTH RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MYOSARCOMA; RHABDOMYOSARCOMA; TUMOR BIOPSY; TUMOR GROWTH;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; CYTOSKELETON; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERMEDIATE FILAMENT PROTEINS; LEIOMYOSARCOMA; LIPOSARCOMA; MALE; MIDDLE AGED; RHABDOMYOSARCOMA; SOFT TISSUE NEOPLASMS;

EID: 0030025710     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199602000-00001     Document Type: Article

References (86)

1. Agamanolis DP, Dasu S, Krill CE Jr. Tumors of skeletal muscle. Hum Pathol 1986;17:778-95.
2. Albores-Saavedra J, Martin RG, Smith JL. Rhabdomyosarcoma. A study of 35 cases. Cancer 1978;41:2250-66.
3. Ariel IM, Briceno M. Rhabdomyosarcoma of the extremities and trunk: analysis of 150 patients treated by surgical resection. J Surg Oncol 1975;7:269-87.
4. Babaï F, Skalli O, Schürch W, Seemayer TA, Gabbiani G. Chemically induced rhabdomyosarcomas in rats. Ultrastructural, immunohistochemical, biochemical features and expression of α-actin isoforms. Virchows Arch B Cell Pathol 1988;55:263-77.
5. Babaï F, Musevi-Aghdam J, Schürch W, Royal A, Gabbiani G. Coexpression of α-sarcomeric actin, α-smooth muscle actin and desmin during myogenesis in rat and mouse embryos. I. Skeletal muscle. Differentiation 1990;44:132-42.
6. Brecher ME, Franklin WA. Absence of mononuclear phagocyte antigens in malignant fibrous histiocytoma. Am J Clin Pathol 1986;86:344-8.
7. Caplan AL, Fiszman MY, Eppenberger HM. Molecular and cell isoforms during development. Science 1983;221:921-7.
8. Cintorino M, Vindigni C, Del Vecchio MT, et al. Expression of actin isoforms and intermediate filament proteins in childhood orbital rhabdomyosarcomas. J Submicrosc Cytol Pathol 1989;21:409-19.
9. deJong AS, van Kessel-van Vark M, Albus Lutter CE. Pleomorphic rhabdomyosarcoma in adults: immunohistochemistry as a tool for its diagnosis. Hum Pathol 1987;18:298-303.
10. Dias P, Parham DM, Shapiro DN, Webber BL, Houghton PJ. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors. Diagnostic utility in rhabdomyosarcoma. Am J Pathol 1990;137:1283-91.
11. Dias P, Parham DM, Shapiro DN, Tapscott SJ, Houghton PJ. Monoclonal antibodies to myogenic regulatory protein MyoD1. Epitope mapping and diagnostic utility. Cancer Res 1992;52:6431-9.
12. Douglass EC, Valentine M, Etcubanas E, et al. A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 1987;45:148-55.
13. Enjoji M, Hashimoto H, Tsuneyoshi M, Iwasaki H. Malignant fibrous histiocytoma. A clinicopathologic study of 130 cases. Acta Pathol Jpn 1980;30:727-41.
14. Enzinger FM. Malignant fibrous histiocytoma 20 years after Stout. Am J Surg Pathol 1986;10:(Suppl)43-53.
15. Enzinger FM, Weiss SW. Malignant fibrohisticytic tumors. In: Soft tissue tumors, 3rd ed. St. Louis, MO: CV Mosby, 1995:355-80.
16. Erlandson R. Diagnostic transmission electron microscopy of tumors. New York: Raven Press. 1994:700-10.
17. Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal of 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 1992;16:213-28.
18. Fletcher CD. Malignant fibrous histiocytoma? Histopathology 1987;11:433-7.
19. Fu YS, Gabbiani G, Kaye GI, Lattes R. Malignant soft tissue tumors of probable histiocytic (malignant fibrous histiocytomas): general considerations and tissue culture studies. Cancer 1975;35:176-98.
20. Fujimoto T, Singer SJ. Immunocytochemical studies of endothelial cells in vivo. I. The presence of desmin, or of desmin plus vimentin, or vimentin only, in the endothelial cell of different capillaries of the adult chicken. J Cell Biol 1986;103:2775-86.
21. Gabbiani G, Kocher O, Bloom WS, Vandekerckhove J, Weber K. Actin expression in smooth muscle cells of rat aortic intimai thickening, human atheromatous plaque and cultured rat aortic media. J Clin Invest 1984;73:148-52.
22. Gaffney EF, Dervan PA, Fletcher CD. Pleomorphic rhabdomyosarcoma in adulthood. Analysis of 11 cases with definition of diagnostic criteria. Am J Surg Pathol 1993;17: 601-9.
23. Hayward LJ, Zhu YY, Schwartz RJ. Cellular localization of muscle and nonmuscle actin nRNAs in chicken primary myogenic cultures: the induction of α-skeletal actin mRNA is regulated independently of α-cardiac actin gene expression. J Cell Biol 1988;106:2077-86.
24. Hennessey ES, Drummond DR, Sparrow JC. Molecular genetics of actin function. Biochem J 1993;291:657-71.
25. Hollowood K, Fletcher CD. Rhabdomyosarcoma in adults. Semin Diagn Pathol 1994;11:47-57.
26. Horn RC, Enterline HT. Rhabdomyosarcoma: a clinicopathological study and classification of 39 cases. Cancer 1958;11:181-99.
27. Iwasaki H, Isayama T, Johzaki H, Kikuchi M. Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin. Immunocytochemical studies with monoclonal anti-MFH antibodies. Am J Pathol 1987;128:528-37.
28. Iwasaki H, Isayama T, Ohjimi Y, et al. A tumor of facultative histiocytes showing mesenchymal differentiation in cultured cell lines. Cancer 1992;69:437-47.
29. Kaufman SL, Stout AP. Histiocytic tumors (fibrous xanthoma and histiocytoma) in children. Cancer 1961;14:469-82.
30. Kearney MM, Soule EH, Ivins JC. Malignant fibrous histiocytoma. A retrospective study of 167 cases. Cancer 1980; 45:167-78.
31. Kempson RL, Kyriakos M. Fibroxanthosarcoma of the soft tissues. A type of malignant fibrous histiocytoma. Cancer 1972;29:961-76.
32. Keyhani A, Booher RJ. Pleomorphic rhabdomyosarcoma. Cancer 1968;22:956-67.
33. Kocher O, Skalli O, Bloom WS, Gabbiani G. Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening. Lab Invest 1984;50:645-52.
34. Lagacé R, Delage C, Seemayer TA. Myxoid variant of malignant fibrous histiocytoma. Ultrastructural observations. Cancer 1979;43:526-34.
35. Lagacé R, Schürch W, Seemayer TA. Myofibroblasts in soft tissue sarcomas. Virchow Arch A Path Anat Hist 1980;389: 1-11.
36. Lattes R. Malignant fibrous histiocytoma. A review article. Am J Surg Pathol 1982;6:761-71.
37. Lawrence JB, Taneja K, Singer RH. Temporal resolution and sequential expression of muscle-specific genes revealed by in situ hybridization. Dev Biol 1989;133:235-46.
38. Lennette DA. An improved mounting medium for immunofluorescence microscopy. Am J Clin Pathol 1978;69:647-8.
39. Linscheid RL, Soule EH, Henderson ED. Pleomorphic rhabdomyosarcoma of the extremities and limb girdles. A clinicopathological study. J Bone Joint Surg 1965;47A:715-26.
40. Miwa T, Manabe Y, Kurokawa K, et al. Structure, chromosome location, and expression of the human smooth muscle (enteric type) τ-actin gene: evolution of six human actin genes. Mol Cell Biol 1991;11:3296-306.
41. O'Brien JE, Stout AP. Malignant fibrous xanthomas. Cancer 1964;17:1445-55.
42. Osborn M, Hill C, Altmannsberger M, Weber K. Monoclonal antibodies to titin in conjunction with antibodies to desmin separate rhabdomyosarcomas from other tumor types. Lab Invest 1986;55:101-8.
43. Ozzello L, Stout AP, Murray MR. Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 1963;16:331-44.
44. Pack GT, Eberhart WF. Rhabdomyosarcoma of skeletal muscle. Report of 100 cases. Surgery 1952;32:1023-64.
45. Parham DM. The molecular biology of childhood rhabdomyosarcoma. Semin Diagn Pathol 1994;11:39-46.
46. Patton RB, Horn RC. Rhabdomyosarcoma. Clinical and pathological features and comparison with human fetal and embryonal skeletal muscle. Surgery 1962;52:572-84.
47. Phelan JT, Juardo J. Rhabdomyosarcomas. Surgery 1962;52: 585-91.
48. Reddick RL, Michelitch H, Triche TJ. Malignant soft tissue tumors (malignant fibrous histiocytoma, pleomorphic liposarcoma and pleomorphic rhabdomyosarcoma): an electron microscopic study. Hum Pathol 1979;10:327-43.
49. Riopelle JL, Thériault JP. Sur une forme méconnue de sarcome des parties molles; le rhabdomyosarcome alvéolaire. Ann Anat Pathol (Paris) 1956;1:88-111.
50. Roholl PJ, Kleyne J, Van Unnik JA. Characterization of tumor cells in malignant fibrous histiocytomas and other soft tissue tumors, in comparison with malignant histiocytes. II. Immunoperoxidase study on cryostat sections. Am J Pathol 1985;121:269-74.
51. Roholl PJ, Eibers HR, Prinsen I, Ciaessens JA, van Unnik JA. Distribution of actin isoforms in sarcomas: an immunohistochemical study. Hum Pathol 1990;21:1269-74.
52. Rooser B, Willen H, Gustafson P, Alvergard TA, Rydholm A. Malignant fibrous histiocytoma of soft tissue. A population-based epidemiologic and prognostic study of 137 patients. Cancer 1991;67:499-505.
53. Sappino AP, Schürch W, Gabbiani G. Differentiation repertoire of fibroblastic cells. Expression of cytoskeletal proteins as marker of phenoty pic modulations. Lab Invest 1990; 63:144-61.
54. Schürch W, Skalli O, Seemayer TA, Gabbiani G. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. I. Smooth muscle tumors. Am J Pathol 1987;128:91-103.
55. Schürch W, Skalli O, Lagacé R, Seemayer TA, Gabbiani G. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. III. Hemangiopericytomas and glomus tumors. Am J Pathol 1990;136: 771-86.
56. Schürch W, Bochaton-Paillat ML, Geinoz A, et al. All histological types of primary human rhabdomyosarcoma express α-cardiac and not α-skeletal actin messenger RNA. Am J Pathol 1994;144:836-46.
57. Schürch W, Seemayer TA, Gabbiani G. Myofibroblast. In: Sternberg SS, ed. Histology for pathologists. New York: Raven Press, 1992:109-44.
58. Scrable H, Witte DP, Lampkin BC, Cavanee WK. Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature 1987;329:645-7.
59. Scrable H, Cavanee W, Ghavimi F, Lovell M, Morgan K, Sapienza C. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci USA 1989;86:7480-4.
60. Scrable H, Witte D, Shimada H, Mol differential pathology of rhabdomyosarcoma. Genes Chromosom Cancer 1989;1: 23-35.
61. Seidal T, Kindblom LG, Angervall L. Rhabdomyosarcoma in middle-aged and elderly individuals. APMIS 1989;97:236-48.
62. Skalli O, Gabbiani G, Babaï F, Seemayer TA, Pizzolato G, Schürch W. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas. Am J Pathol 1988;130:515-31.
63. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against α-smooth muscle actin. A new probe for smooth muscle differentiation. J Cell Biol 1986;103:2787-96.
64. Skalli O, Schürch W, Seemayer TA, et al. Myofibroblasts from diverse pathological settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest 1989;60:275-85.
65. Skalli O, Vandekerckhove J, Gabbiani G. Actin isoform pattern as a marker of normal and pathological smooth muscle and fibroblastic tissues. Differentiation 1987;33:232-8.
66. Soini Y, Miettinen M. Widespread immunoreactivity for alpha-1-antichymotrypsin in different types of tumors. Am J Clin Pathol 1988;90:131-6.
67. Soini Y, Miettinen M. Alpha-1-anti-trypsin and lysozyme. Their limited significance in fibrohistiocytic tumors. Am J Clin Pathol 1989;91:515-21.
68. Stamenkovic I, Skalli O, Gabbiani G. Distribution of intermediate filament proteins in normal and diseased human glomeruli. Am J Pathol 1986;125:465-75.
69. Stout AP. Rhabdomyosarcoma of the skeletal muscles. Ann Surg 1946;123:447-72.
70. Stout AP. Tumors of soft tissues. Washington D.C.: Armed Forces Institute of Pathology. 1953, p. 89-96. (Atlas of tumor pathology, Fasc. 5).
71. Toccanier-Pelte MF, Skalli O, Kapanci Y, Gabbiani G. Characterization of stromal cells with myoid features in lymph nodes and spleen in normal and pathologic conditions. Am J Pathol 1987;129:109-18.
72. Tallini G, Parham DM, Dias P, Cordon-Cardo C, Houghton PJ, Rosai J. Myogenic regulatory protein expression in adult soft tissue sarcomas: a sensitive and specific marker for skeletal muscle differentiation. Am J Pathol 1994;144:693-701.
73. Tonin PN, Scrable H, Shimada H, Cavanee WK. Muscle specific gene expression in rhabdomyosarcomas and stages of human fetal muscle development. Cancer Res 1991;51: 5100-6.
74. Turc-Carel C, Lizard-Nacol S, Justrabo E, Favrot M, Philip T, Tabone E. Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 1986; 19:361-2.
75. Vandekerckhove J, Weber K. At least six different actins are expressed in a higher mammal: an analysis based on the amino acid sequence of the amino-terminal tryptic peptide. J Mol Biol 1978;126:783-802.
76. Vandekerckhove J, Weber K. The complete amino acid sequence of actins from bovine aorta, bovine heart, bovine fast skeletal muscle, and rabbit slow skeletal muscle. A protein-chemical analysis of muscle actin differentiation. Differentiation 1979;14:123-33.
77. Vanderkerckhove J, Weber K. Actin typing on total cellular extracts. A highly sensitive protein-chemical procedure able to distinguish different actins. Eur J Biochem 1981;113:595-603.
78. Wang-Wuu S, Soukup S, Ballard E, Gotwals B, Lampkin B. Chromosomal analysis of sixteen rhabdomyosarcomas. Cancer Res 1988;48:983-7.
79. Weber CO. Anatomische Untersuchung einer hypertrophischen Zunge nebst Bemerkungen über die Neubildung quergestreifter Muskelfasern. In: Virchow R, ed. Archiv für pathologische Anatomie und Physiologie und für klinische Medizin, Vol. VII, 1854:115-25.
80. Weiss SW, Malignant fibrous histiocytoma. A reaffirmation. Am J Surg Pathol 1982;6:773-84.
81. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma. An analysis of 200 cases. Cancer 1978;41:2250-66.
82. Weiss LM, Warhol MJ. Ultrastructural distinction between adult pleomorphic fibrous histiocytomas. Hum Pathol 1982; 15:1025-33.
83. Wesche WA, Fletcher CDA, Dias P, Houghton PJ, Parham DM. Immunohistochemistry of MyoD1 in adult pleomorphic soft tissue sarcomas. Am J Surg Pathol 1995;19:261-9.
84. Wood GS, Beckstead JH, Turner RR, Henderickson MR, Kempson RL, Warnke RA. Malignant fibrous histiocytoma tumor cells resemble fibroblasts. Am J Surg Pathol 1986;10: 323-35.
85. Yokoi Y, Namihisa T, Kuroda H, et al. Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology 1984;4:709-14.
86. Yun K. A new marker for rhabdomyosarcoma. Insulin-like growth factor II. Lab Invest 1992;67:653-64.